Indices Of Lipid Metabolism Research Articles

Intermittent cold stimulation affects energy metabolism and improves stress resistance in broiler heart

To investigate the effect of intermittent cold stimulation on cardiac energy metabolism and cold resistance of broilers, 288 broilers were divided into 3 groups: control group (CC) and 2 cold stimulation groups (CS3 and CS9). The CS3 and CS9 groups received cold stimulation at temperatures of 3°C and 9°C lower than CC group for 5 h from d 15 to 35. Three groups were subjected to acute cold stress (ACS) of 10°C for 12 and 24 h at 44 d. Performance, cardiac histopathological changes, heat shock proteins (HSPs), and lipid metabolism levels were measured. Results showed that the performance was not different among groups at 22 and 29 d (P > 0.05), but the mRNA levels of Acyl CoA synthase long-chain family member 1 (ACSL1) and acyl-coenzyme oxidase (ACO) in CS group were upregulated compared to CC group (P < 0.05). At 36 d, the performance of the CS3 group was better than the other 2 groups, myocardial structure was normal and other lipid metabolism indexes, except for peroxisome proliferator-activated receptor coactivator 1α (PGC-1α) levels, were similar to those of CC group (P > 0.05). The myocardial fiber disorder, Triglyceride (TG), and leptin (LEP) contents were significantly lower in CS9 group than in CC and CS3 groups at 36 d (P < 0.05). The HSP protein levels were significantly higher in CS group than in CC group before ACS (P < 0.05). After 24 h of ACS, the mRNA of lipid metabolism genes, the protein levels of HSP40 and HSP60, and the contents of TG and LEP in the CS3 group were upregulated compared to other groups. The CC and CS9 groups showed myocardial structure was destroyed, with lower TG and LEP levels compared to before ACS (P < 0.05). Therefore, cold stimulation at 3°C lower than the normal feeding temperature for 5 h did not impair performance but can increase the resistance of broilers to ACS by promoting lipid metabolism.

The state of lipid metabolism indicators and the system of peroxidation — antioxidant protection in aluminum production workers with occupational bronchopulmonary pathology

Introduction. In aluminum production workers, the most common occupational pathology is bronchopulmonary diseases, which are characterized by the formation of comorbid pathologies. Oxidative stress plays a key role in the pathogenesis of bronchopulmonary and cardiovascular pathologies.&#x0D; The study aims to research the indicators of oxidative metabolism and antioxidant protection in aluminum production workers with occupational bronchopulmonary pathology (OBPP) during work and post-contact period.&#x0D; Materials and methods. During the study, on the basis of the therapeutic department of the clinic at East-Siberian Institute of Medical and Ecological Research, scientists examined 130 patients — workers of aluminum production, with an established professional diagnosis of the bronchopulmonary system both during work and in the post-contact period. The authors have analyzed the indicators of oxidative stress, lipid metabolism and the concentration of antibodies to oxidized low-density lipoproteins.&#x0D; Results. In patients with OBPP, decreased superoxide dismutase activity was more common during work than in the post-exposure period. About 60% of the examined patients had elevated cholesterol levels, almost 40% had higher reference values of the atherogenicity index and the content of antibodies to oxidized low-density lipoproteins. Cholesterol levels in high-density lipoproteins in individuals with OBPP in the long-term period were lower than in individuals with the same pathology during the work period.&#x0D; Conclusion. The depletion of antioxidant protection in workers in the post-contact period of the OBPP, the researchers noted in the form of a decrease in the activity of superoxide dismutase in every third person examined, which can lead to the formation of endothelial dysfunction. An increase in the fractions of atherogenic cholesterol is accompanied by a significant increase in the occurrence of a reduced level of high-density lipoprotein cholesterol, which has anti-atherogenic properties.&#x0D; Ethics. The examination of patients met ethical standards in accordance with the Helsinki Declaration of the World Association "Ethical Principles of Conducting Scientific Medical Research with Human Participation", as amended in 2000 and the "Rules of Clinical Practice in the Russian Federation", approved by Order of the Ministry of Health of the Russian Federation No. 266 of 06/19/2003. All the surveyed signed an informed consent to participate in the study. The protocol of the study was approved by the Ethics Committee of the East Siberian Institute of Medical and Environmental Research (Protocol No. 6 of 10.03.2020).

Age-related determinants of the metabolic syndrome in women of reproductive age of the main ethnic groups of the Baikal Region

The aim of the study. To determine the age limit of the initial manifestations of the metabolic syndrome in women of reproductive age of the Caucasian and Asian ethnic groups. Materials and methods. The study included women of reproductive age of the Russian and Buryat ethnic groups (n = 1231). We carried out general clinical examination, studied glycemia levels and lipid metabolism indicators. The analysis of the components of the metabolic syndrome was performed taking into account age characteristics and ethnicity. Threshold values for the age of metabolic disorders manifestation were determined. Results. It was found that the main components of the metabolic syndrome in women of reproductive age of the Russian and Buryat ethnic groups were a decrease in high-density lipoprotein (HDL), an increase in waist circumference, and an increase in blood pressure. The age-related determinants of the metabolic syndrome in the population of women of reproductive age in the Baikal region were determined. It was shown that the age-related determinants of the metabolic syndrome in Caucasian and Asian women do not differ significantly and amount to 33.5 years (95% confidence interval (95% CI): 32.5; 38.5) and 36.5 years (95% CI: 27.5; 52.5), respectively. A universal critical age value was determined as 34.5 years (95% CI: 32.5; 38.5), which is associated with a significant increase in the prevalence of the metabolic syndrome in accordance with the ATP III criteria. The ranking of metabolic syndrome criteria in the studied groups revealed the following order of their occurrence: the decrease in HDL index prevailed, followed by the increase in waist circumference, blood pressure, glucose and triglycerides; no dependence on the ethnicity was found. Conclusion. When assessing the age-related determinants of the metabolic syndrome in the mixed Caucasoid-Asian group, it is advisable to use universal approaches, taking into account the cut-off point of age, which is 34.5 years. The determination of age criteria for the correct classification of patients with respect to the manifestations of the metabolic syndrome is necessary to analyze the contribution of the age factor to the implementation of various metabolic syndrome predictors, to develop prognostic models, and to use effective age-determined markers of metabolic disorders.

Study of association of the polymorphism rs1799883 of the &lt;i&gt;FABP2&lt;/i&gt; gene in children with bronchial asthma associated with obesity

Introduction. Currently, there is a separate phenotype “bronchial asthma – obesity”, manifested by a more severe course of the disease, low rates of achieving asthma control, resistance to basic therapy. Asthma, like obesity, is recognized as a classic example of multifactorial diseases, which are based on a rather complex gene network. The active search for genetic markers characterizing individual characteristics of human metabolism continues. Of particular interest are the genes involved in the regulation of fat and carbohydrate metabolism.Aim. Analysis of associations of polymorphic loci Ala54Thr (G163A) of the FABP2 gene with bronchial asthma of varying severity and control of asthma in children.Materials and methods. 161 children with bronchial asthma in remission were examined by a continuous sampling method, of which 59 patients with obesity of 1-3 degrees without concomitant endocrine pathology. The examination included general clinical, functional, and instrumental methods. The level of asthma control was determined according to the GINA criteria (2018). The biochemical study was carried out on an automatic analyzer SAPPHIRE 400 (Japan). The study of gene polymorphisms was carried out by real-time polymerase chain reaction using sets of “Metabolism” (Research and Production Company “Litekh”, Moscow) on the CFX-96 Biorat device (USA).Results. We have not identified associations of the presence of polymorphic loci of the FABP2 gene with obesity. It was determined that in children with bronchial asthma, the frequency of carrying the homozygous genotype Thr/Thr and the minor allele Thr increased by 1.5 times compared to the control group (OR 9.043; 95%CI [2,093–39,073], p=0.0011 and OR 2.946; 95%CI [1,698‒5,111], p=0.001, respectively), and in children with bronchial asthma with and without asthma control, the carriage of the homozygous Thr/Thr genotype and the rare A allele increased the risk of uncontrolled bronchial asthma (OR 2.42; 95%CI [1.23‒4.79], p=0.03 and OR 1.75; 95%CI [1,119‒2,736], p=0.01), the frequency of the homozygous Ala/Ala genotype and the frequent Ala allele was detected 1.5 times more often in children with bronchial asthma associated with obesity (OR 2.176; 95%CI [1.001‒4.727], p=0.0008 and OR 2.378; 95%CI [1.495‒3.780], p=0.0002, respectively).Conclusion. Although we have not identified associations of the presence of polymorphic loci of the FABP2 gene with obesity, it has been shown that children with Ala54Thr+Thr54Тhr genotypes have significantly higher glucose levels (4.9±0.06 mmol/L compared with carriers of the Ala54Ala genotype 4.0±0.06 mmol/L, p&lt;0.001), cholesterol (4.8±0.4 mmol/L compared with carriers of the Ala54Ala genotype 3.93±0.1 mmol/L, p&lt;0.05) and low density lipoproteins (2.55±0.09 mmol/L compared with carriers of the Ala54Ala genotype 2.26±0.1 mmol/L, p&lt;0.05). There is an obvious need for further investigation of the effect of gene polymorphism on the indicators of carbohydrate and lipid metabolism, depending on the nature of diets. These issues require further study as part of the search for probable cause-and-effect relationships and the creation of personalized programs depending on polymorphic gene variants.

Гістеректомія в період менопаузального переходу як предиктор метаболічних порушень

Although data on the decrease in ovarian function after hysterectomy (GE) are found in literature sources, the nature of changes in the hormonal and metabolic profile, its chronological sequence, the issue of the relationship with the development of metabolic syndrome (MS), even in the case of preservation of ovarian tissue, remain controversial and fragmented, which served as an impetus for conducting this study. Purpose - to assess the risk of metabolic disorders after GE during the menopausal transition. Materials and methods. A comprehensive assessment of the long-term consequences of GE was carried out in 160 women of the menopausal transition age. Metabolic homeostasis parameters were evaluated before surgery and in dynamics after surgical intervention (after 12 months). Risk factors were identified during a general clinical examination, based on anamnestic data. Indicators of carbohydrate and lipid metabolism were evaluated in the examined women. Inclusion criteria: the age of the menopausal transition, GE due to benign uterine pathology, the patient's consent to participate in the research. Results. Analysis of carbohydrate metabolism indicators showed an increase in the HOMA-IR index and postprandial glucose level, changes in the lipid profile. When comparing clinical symptoms and laboratory research methods, in 34.37% of cases, the formation of MS was noted one year after GE. Based on multivariate analysis using binary logistic regression, the following risk factors for metabolic disorders were found to be statistically significant: high body mass index, waist circumference above 80 cm, age older than 45, climacteric syndrome, GE. Conclusions. A high body mass index, a waist circumference greater than 80 cm, the presence of signs of the climacteric syndrome, GE and age older than 45 years show the association with the development of metabolic disorders in the distant postoperative period, and their combined effect increases the risk of their development. These factors at the preoperative stage can serve as prognostic markers of metabolic disorders in the distant postoperative period. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways

Objective GuizhiFulingWan (GFW) has been reported to be effective against polycystic ovary syndrome (PCOS) by possessing oxidative stress and inflammation which related to PI3K/AKT/NF-κB, Nrf2/HO-1 pathway. This study aims to probe the effects and mechanisms of GFW combined with rosiglitazone on PCOS via PI3K/AKT/NF-κB and Nrf2/HO-1 pathways. Methods A rat PCOS model established by dehydroepiandrosterone (DHEA) injection. The experiment was allocated to control, DHEA, GFW, rosiglitazone, GFW + rosiglitazone groups. Treatment for 30 days, we monitored weight and ovarian weight of rats. Fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), lipid metabolism indexes, estrous cycle and sex hormone-, inflammation-, oxidative stress-related factors were examined. Hematoxylin&eosin staining assessed ovarian tissue pathological changes. Western blot determined PI3K/AKT/NF-κB, Nrf2/HO-1 pathways-related markers. Results GFW and rosiglitazone treatment suppressed body weight and ovarian weight in PCOS rats. They also decreased FBG, FINS, HOMA-IR while inhibited total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and enhanced high-density lipoprotein (HDL). They ameliorated estrous cycle, ovarian histological changes and follicular development. They restrained testosterone (T), luteinizing hormone (LH) and accelerated estradiol (E2), progesterone (P), follicle stimulating hormone (FSH). They inhibited glutathione peroxidase (GSH-Px), malondialdehyde (MDA), superoxide dismutase (SOD) in serum while increased GSH-Px, SOD and decrease MDA in ovarian tissues. They reduced C-reactive protein, interleukin-18 (IL-18), tumor necrosis factor-α (TNF-α), IL-6, IL-1β levels. GFW and rosiglitazone co-intervention regulated PI3K/AKT/NF-κB and Nrf2/HO-1 pathways in PCOS rats. Conclusion GFW alleviated ovarian dysfunction in PCOS rats, which may be related to the PI3K/AKT/NF-κB, Nrf2/HO-1 pathways.

The correlation between body weight, serotonin levels, mental health status, sleep disorders and metabolism in patients with obesity

Background. The significant spread of obesity stimulates researchers to search for etiopathogenic treatment by studying the relationships and dependencies of the hormonal, neurochemical and psychosomatic components. The purpose of the study is to determine the correlation between body weight, serotonin level, mental health status, sleep disorders and metabolism in obese patients. Materials and methods. In a cohort, prospective study, 75 patients with obesity were observed for 6 months. They were divided into 2 groups depending on the detected psychosocial characteristics and sleep disorders with the appropriate treatment using a patient-oriented approach. The examination included studying body mass index (BMI), abdominal obesity indices (body surface area, waist/hip ratio, conicity index, a body shape index, abdominal volume index), blood pressure, lipid profile, fasting glucose, insulin, leptin, serotonin, assessment of psychosocial status and sleep quality with Hospital Anxiety and Depression Scale (HADS), Beck’s Depression Inventory (BDI), Hamilton Anxiety Rating Scale (HAM-A), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), quality of life using the SF-36 questionnaire. Statistical analysis was performed using IBM SPSS Statistics, Statistica 12, Excel 2010. Results. At baseline, the patients had obesity class I and II. Тhe calculated indices of abdominal obesity, indicators of lipid and carbohydrate metabolism, scores of questionnaires of eating behavior, anxiety and depression, quality of sleep, sleepiness and leptin level exceeded the recommended values, while the level of serotonin, the scores of the SF-36 had low values that significantly improved in dynamics. Strong direct correlations at baseline were found between BMI, abdominal obesity indices, blood pressure, indicators of lipid and carbohydrate metabolism, leptin, HADS, BDI, HAM-A, ESS, PSQI global score; a strong inverse (negative) relationship was noted between BMI and the levels of high-density lipoprotein and serotonin. A high negative correlation was found between serotonin and BMI, abdominal obesity indices (body surface area, a body shape index, abdominal volume index, conicity index), blood pressure, indicators of lipid and carbohydrate metabolism, HADS, HAM-A, BDI, PSQI global score, sleep quality, latency, duration, efficiency and the ESS. Conclusions. The high BMI correlates with a low level of serotonin, increased level of anxiety and depression, drowsiness, deterioration of the quality of sleep and life, disorders of lipid and carbohydrate metabolism, which are mutually aggravating factors for the development of obesity and other non-infectious diseases; it must be taken into account when determining approaches to comprehensive patient-oriented treatment of obesity.

Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease

Bayesian network Meta-analysis was employed to compare the efficacy of different oral Chinese patent medicines in treating type 2 diabetes mellitus with angina pectoris of coronary heart disease. Randomized controlled trial(RCT) of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease were retrieved from 8 Chinese and English databases including CNKI, Wanfang, VIP, SinoMed, EMbase, PubMed, Cochrane Library, and Web of Science with the time interval from inception to November 2022. The BUGSnet package in R 4.2.1 was used to conduct Meta-analysis. A total of 45 RCTs were included, involving 4 727 patients and 7 oral Chinese patent medicines. Network Meta-analysis showed that the conventio-nal western medicine combined with Chinese patent medicines improved the outcome indicators. Shexiang Baoxin Pills + conventional western medicine had the best effect on reducing the incidence of adverse cardiovascular events, and Yixinshu Capsules + conventional western medicine on reducing the frequency and duration of angina pectoris. The conventional western medicine combined with oral Chinese patent medicines can reduce blood glucose indicators. Yindan Xinnaotong Soft Capsules + conventional western medicine had the best effect on reducing fasting blood glucose(FBG), 2 hours postprandial blood glucose(PBG), and glycosylated hemoglobin(HbA1c). The conventional western medicine combined with oral Chinese patent medicines can reduce blood lipid indicators. Yixinshu Capsules + conventional western medicine had the best effect on reducing total cholesterol(TC) and low density lipoprotein-cholesterol(LDL-C), and Yindan Xinnaotong Soft Capsules + conventional western medicine on reducing triglyceride(TG). Current evidence suggests that the patients with type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease could reasonably choose oral Chinese patent medicines on the basis of routine antiplatelet, anticoagulant, hypoglycemic, and antihypertensive therapies, which could reduce the incidence of adverse cardiovascular events, alleviate the symptoms of angina pectoris, and reduce the glucose and lipid metabolism indicators. Shexiang Baoxin Pills + conventional treatment and Yixinshu Capsules + conventional western medicine have better effect on angina pectoris, Yindan Xinnaotong Soft Capsules + conventional western medicine on lowering blood glucose, and Yindan Xinnaotong Soft Capsules + conventional western medicine and Yixinshu Capsules + conventional western medicine on reducing blood lipid. Due to the lack of direct comparative results between Chinese patent medicines and other factors, high-quality studies remain to be carried out for further verification.

Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder.

The purpose of this study was to explore the relationship between hemoglobin levels and metabolic disorders in patients with PCOS. A total of 573 patients were selected, based on the hemoglobin level; 342 patients with PCOS were divided into two groups as follows: Group A (normal Hb group, n = 269) and Group B (high Hb group, n = 73); 231 non-PCOS patients were divided into two groups as follows: Group C (normal Hb group, n = 199), and Group D (high Hb group, n = 32). The general information, glucose and lipid metabolism indicators, and uric acid levels of all patients were compiled for data analysis. (1) Hb, HGB concentration in mean red blood cells and RDW in PCOS patients were higher than those in non-PCOS patients, and MCV was lower than that in non-PCOS patients (P < 0.05); (2) Compared with Group A, patients in Group B had higher BMI, Hb, 2-hPG, FINS, 2-hINS, HOMA-IR, LDL-C, and uric acid levels while the QUICKI was lower; in Group C, the age, FSH, HDL-C, and LDL-C were higher, and AMH, BMI, T, TG, and uric acid level were lower (P<0.05); compared with Group D, AMH, BMI, FINS, HOMA-IR, TG, uric acid level increased, while age, FSH, and QUICKI decreased in Group B; and Hb and T decreased in Group C (P<0.05); (3) Pearson's correlation analysis indicated that Hb in PCOS patients was positively correlated with BMI, FPG, 2-hPG, FINS, 2-hINS, and HOMA-IR, and negatively correlated with the QUICKI (P<0.05); (4) Multi-factor logistic regression analysis suggested that the high Hb level in PCOS patients was an independent risk factor of IR (P<0.05). Hb level in patients with PCOS was associated with BMI and glucose metabolism indicators; a high Hb level may be an independent risk factor for IR.

The effects of wartime stress factors on the development and progression of non-alcoholic fatty liver disease

Objective — to analyze the risk factors of the disease course, to evaluate metabolic factors and biochemical markers of inflammation in patients with non‑alcoholic fatty liver disease (NAFLD) who were affected by stress during martial law. Materials and methods. Examinations involved 42 patients with NAFLD who were affected by stress during military operations, and 20 subjects of the control group. Investigations included questionnaire survey, determination of the quantitative and qualitative state of visceral lipid tissue (VLT) with the use of OMRON BF‑511 body composition monitor scales. Levels of the carbohydrate and lipid metabolism indicators, markers of hepatocyte damage and systemic inflammation were determined using standard diagnostic methods. Statistical data processing was performed using the statistical program package «SPSS 17.0» (SPSS, USA). Results. A questionnaire has been developed to determine risk factors for the occurrence and progression of NAFLD during wartime. According to the results of the questionnaire survey of NAFLD patients, the influence of stress factors on the general condition of patients was revealed, in particular, 71.4% of patients experienced a decrease in mood, a feeling of anxiety and fear, excessive worry for various reasons, a feeling of tension and inability to relax (59.5%), which was accompanied by difficulties with falling asleep, restless intermittent sleep in 66.7% of cases. Patients with NAFLD demonstrated the greatest expressiveness of general weakness and rapid fatigue. In more than 2/3 of the examined patients, there was a violation of the nutrition regime, limitation of physical activity, deterioration of the quality of food and drinking water. During the war, most respondents (73.8%) experienced an exacerbation of chronic metabolic diseases. In patients with NAFLD who were under the influence of negative factors of the war period, a significant increase in the VLT levels was observed in the groups with both normal and excessive weight, and in the group with obesity (9% and 17%), which is probably due to the potential effects of the stressful wartime factors to increase the number and activity of hormonally active VLT. The significant increase in the levels of fasting glucose and markers of insulin resistance, an increase in the activity of liver transaminases and C‑reactive protein levels compared to the pre‑war period were revealed in the examined patients. Conclusions. The main epigenetic factors that could potentially affect the NAFLD course during the active military operations, were identified and evaluated. The most significant manifestations were psycho‑emotional disorders in the form of asthenic and anxiety‑depressive disorders, violations of the regime and quality of nutrition. In NAFLD patients who were affected by the negative consequences of hostilities, the significant increase in the level of fasting glucose and markers of insulin resistance was found, which is probably related to the negative effect of wartime stress factors. An increase in the activity of hepatic transaminases and the level of CRP in NAFLD patients who were affected by hostilities compared to the pre‑war period was revealed. These changes cause a more severe course of NAFLD in wartime conditions and may contribute to the rapid progression of the disease in the future.

Comparative assessment of the state of main arteries in workers of the pivotal occupations in the coal and aluminum industries

Introduction. To prevent cardiovascular accidents and preserve the employability in workers in the pivotal occupations of the coal and aluminum industries it is required timely identification of risk groups for long-term asymptomatic damage to the atherosclerotic process of the arteries.&#x0D; Material and methods. The study included two hundred twenty two miners and 109 workers in the aluminum industry aged of 40–55 years (average age of miners – 47.1 ± 0.36 years, metallurgists – 47.64 ± 0.43 years, р = 0.367). All subjects underwent ultrasound investigation of the carotid and femoral arteries. Also anamnestic, anthropometric data, the presence of arterial hypertension, indices of lipid and carbohydrate metabolism were evaluated.&#x0D; Results. Miners were more often diagnosed with intimal thickening (41.9% vs. 27.5%, p = 0.011), in contrast to aluminum production workers, who were significantly more likely to have atherosclerotic plaques (57.8% vs. 43.2%, p = 0.0127). The frequency of generally accepted risk factors for atherosclerosis in both occupational cohorts (arterial hypertension, smoking, carbohydrate metabolism disorders, physical inactivity, obesity) was detected without significant differences. Miners with atherosclerosis were diagnosed with significantly higher average values of total cholesterol and low-density lipoprotein cholesterol, metallurgists with atherosclerosis showed hypertriglyceridemia.&#x0D; Limitations. The study was limited by the number of the examined persons undergoing periodic medical examination at the Research Institute for Complex Problems of Hygiene and Occupational Diseases.&#x0D; Conclusion. A more significant lesion of the main arteries in the form of atherosclerotic plaques with varying degrees of stenosis was found in aluminum production workers compared to miners, which was probably due to the more aggressive influence of harmful production factors in metallurgists. In this regard, it is recommended to conduct a screening ultrasound investigation of the main arteries at a periodic medical examination, which will identify a risk group for the timely prevention of cardiovascular complications.

Nutritional Status of Patients with Chronic Critical Illness

Material and methods. We examined 23 patients with chronic critical illness who were in a minimally conscious state (MCS) with 10.9±2.5 scores on the FOUR (Full Outline of Unresponsiveness) Score Coma Scale. Indicators of carbohydrate, lipid, protein and energy exchange metabolism were evaluated using specimens sampled in the morning hours. Nutritional support was provided by isocaloric isonitrogenic mixtures.Results. Blood biochemistry showed decreases in total protein and albumin levels in 86.9% and 91.3% of patients, respectively. The tests also revealed decreased concentrations of several amino acids, including essential amino acids: histidine (38.3±13.07 µmol/l), methionine (12.68±3.81 µmol/l), threonine (61.6 [58.5;87.7] µmol/l), tryptophan (33.06±15.95 µmol/l), and non-essential amino acids: arginine (40.50 [22.2; 46.9] µmol/l), glutamic acid (124.5±39.29 µmol/l), tyrosine (37.97±10.12 µmol/l). Some correlations between the concentrations of individual amino acids and other indicators were revealed, such as histidine and CRP (r=–0.68, P=0.043), tryptophan and CRP (r=–0.86, P=0.002), histidine and leukocyte count (r=–0.76, P=0.015), methionine and lysine (r=0.88, P=0.008), methionine and patient's weight (r=–0.68, P=0.042). A relationship between threonine concentration and the level of consciousness on the FOUR scale (r=–0.73, P=0.037) was also found. All patients demonstrated significant alterations of carbohydrate and lipid metabolism.Conclusion. Alteration of adequate protein metabolism seems to be the most affected constituent in the nutritional status of patients with chronic critical illness. It is manifested by a decrease in the concentration of total protein and a number of essential and non-essential amino acids, which implies the importance of highprotein nutritional support and correction of the amino acid profile.

The impact of irradiation on ginsenoside variations in red ginseng and its hypoglycemic effects in type 1 diabetic mice

This study aimed to investigate the impact of irradiation on the saponin content in red ginseng extract (ISERG) and its hypoglycemic effects using high-performance liquid chromatography and in vivo experiments. The results revealed a significant increase in the levels of red ginseng ginsenosides Rh4 and CK by 75.56% and 59.32% respectively after exposure to 15 kGy 60Co-γ irradiation. Furthermore, the administration of 500 mg/kg·BW 15 kGy 60Co-γ irradiated ISERG for 32 days demonstrated notable reductions in blood sugar levels and increased insulin levels in Type 1 Diabetes Mellitus (T1DM) mice. Moreover, it effectively improved glucose and lipid metabolism, organ coefficient, and antioxidant related indicators in T1DM mice. The study also observed improvements in the expression levels of InsR, IRS1, and Sirt6 proteins, suggesting their potential in diabetes treatment. These findings highlight the promising application of irradiated red ginseng in the future.

Effects of leonardite and lignite on blood parameters in rats exposed to lead acetate

The study aimed to research in vivo changes in the hematological and biochemical parameters of laboratory rats' blood when they were continuously exposed to a moderate dose of lead acetate while receiving humic feed additives made of leonardite and lignite. Two-month-old white rats were used to assess the detoxifying properties of the humic compounds leonardite and lignite. The analog pair approach was used to create four groups of eight animals from 32 male laboratory rats for the study. Rats received a pre-meal injection of lead acetate at a dose of 7 mg/100 g of animal weight (1/110 LD50) using a veterinary feeding needle. By creating solutions from lignite and leonardite at a dosage of 18 and 25 mg/kg depending on the active ingredient, humic feed additives were supplied to animals. It has been demonstrated that lignite- and leonardite-based feed additives may affect the morphological parameters of lead acetate-treated rats' blood, including hemoglobin, hematocrit, erythrocyte, and platelet count. These parameters were very near to the levels of the intact rats, which suggests that these humic feed additives may have an anti-anemic impact. The effects of feed additives from leonardite and lignite on laboratory rats in groups that were also exposed to a toxic agent for all 21 days of the experiment led to the normalization of markers of the state of protein metabolism in the group of intact animals (serum protein, albumins, urea, creatinine), particularly activity of the enzyme’s aspartate aminotransferase and alanine aminotransferase. As one of the most crucial indicators of lipid metabolism together with cholesterol, the concentration of triglycerides was slightly lower in the humic substances treated groups than in the intact animals. It was discovered that using a feed supplement made from leonardite in a dosage of 18 mg/kg, which contained more fulvic acids than lignite, led to more favorable blood test results in the research group.

Beneficial effects of pioglitazone and α-lipoic acid in patients with polycystic ovaries syndrome.

Changes in hormone levels, improper lipid metabolism, and oxidative stress all significantly contribute to the pathogenic process of polycystic ovarian syndrome (PCOS). According to earlier research, pioglitazone and alpha-lipoic acid are crucial in the emergence of PCOS. The beneficial effects of pioglitazone and alpha-lipoic acid on PCOS were examined in the current study. The 120 patients with PCOS received three months of treatment in pioglitazone groups (n=40 case, 30 mg/time, 1 time/day), α-lipoic acid (n=40 case, 0.6 g/time, 1 time/day), and combination therapy (n=40 case, pioglitazone 30 mg/time, 1 time/day and α-lipoic acid, 0.6 g/time, 1 time/day). Before and after therapy, the following factors were evaluated: the hormonal profile, fasting serum insulin, body weight, body mass index (BMI), menstruation status, oxidative stress, and indications of lipid metabolism. The combination of pioglitazone and α-lipoic acid has a significantly improving effect on BMI, body weight, oxidative stress levels, lipid metabolism, and menstrual status. A significant increase in body weight, BMI, and follicle-stimulating hormone (FSH) levels were found in mice after being treated with α-lipoic acid alone. However, the use pioglitazone alone improves body weight, BMI, the calculation of insulin resistance index (HOMA-IR), Area under the curve (AUC)-insulin, fasting glucose/insulin (G/I) ratio, total testosterone, and malondialdehyde (MDA) levels in post-treatment than pre-treatment. These findings suggest that pioglitazone alone has a better effect than alpha-lipoic acid in improving oxidative stress levels, BMI, and menstrual cyclicity. Additionally, treatment with pioglitazone and alpha-lipoic acid did demonstrate a greater effect than monotherapy with each medication alone.

The role of homocystein in the progression of cardiovascular diseases

Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): grant research A number of studies have shown a relationship between the progression of atherosclerosis and atherocalcinosis and an increase in homocysteine levels. The purpose of the study: to evaluate the role of homocysteine (HC) in the progression of cardiovascular diseases (CVD). Material and methods 150 persons aged 40-70 were examined. When assessing cardiovascular risk (CVR), an updated SCORE algorithm was used - SCORE2 - the risk of death and fatal cases of CVD. The patients were divided into groups: group 1 consisted of persons with low and moderate cardiovascular risk (56 patients), group 2 - with high cardiovascular risk (47), and group 3 - persons with very high cardiovascular risk, but without coronary diseases (8 patients), group 4 - 49 patients with diagnosed coronary diseases. The control group consisted of 20 healthy individuals. The examination included: assessment of hemodynamic parameters (BP), indicators of lipid metabolism (total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL) and low density (LDL), determination of homocysteine levels by a biochemical method. Results According to the results of our study, there was a tendency to increase the level of total cholesterol, LDL in people with low and moderate risk, with a significant increase in people with high CVR by 12.5% (p&amp;lt;0.05), 26% (p&amp;lt;0.001); in persons with very high CVR without coronary CVD by 15.1% (p&amp;lt;0.05), 32% (p&amp;lt;0.001); in persons with very high cardiovascular risk with coronary CVD by 13.4% (p&amp;lt;0.05), 20.8% (p&amp;lt;0.05), respectively, compared with the control group. The level of homocysteine in the blood fluctuates around 10–11 µmol/l. According to a number of authors, the level of homocysteine in the blood plasma is 5–15 µmol / L. Hyperhomocysteinemia is diagnosed when the level of homocysteine in the blood exceeds 15 µmol/L. The results of our study showed an increase in serum homocysteine levels with significant values in patients with very high CVR in groups 3 and 4 with an increase of 35.8% (p&amp;lt;0.05) and 39.7% (p&amp;lt;0.05) respectively, compared with the indicators of the control group and in patients with CVD in group 4 was 15.5±7.2 µmol/l. The results of our study confirm the role of hyperhomocysteinemia as a marker of CVD - in patients with pathology of the cardiovascular system, there is a tendency to hyperhomocysteinemia. Also, the revealed dependence of the level of hyperhomocysteinemia with the level of CVR draws attention. A direct correlation was found between the level of homocysteine and low density lipoproteins (r = 0.76). Сonclusion. Thus, according to the results of our study, it was noted that in the group of very high cardiovascular risk in groups 3 and 4, an increase in the level of homocysteine was detected in group 4 with hyperhomocysteinemia with a level of 15.5±7.2 µmol/l. The dependence of the level of hyperhomocysteinemia with the level of CVR and LDL was revealed.

Inflammation mediates the effect of adiposity and lipid metabolism indicators on the embryogenesis of PCOS women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Polycystic ovary syndrome (PCOS) is a complex reproductive endocrine and metabolic disease affecting women of reproductive age. The low-grade chronic inflammation in PCOS is considered to be associated with obesity and dyslipidemia. We aim to investigate the potential mediating role of white blood cell (WBC) count, a representative inflammatory marker, in the effect of adiposity and lipid metabolism indicators on IVF/ICSI outcomes in PCOS women. We conducted a retrospective cohort study of 1,534 PCOS women who underwent their first IVF/ICSI cycles with autologous oocytes at a reproductive center from January 2018 to December 2020. The associations between PCOS women's adiposity and lipid metabolism indicators and WBC count and IVF/ICSI outcomes were examined using multivariable generalized linear models. Mediation analyses were conducted to evaluate the possible mediating role of WBC count. We found significant dose-dependent correlations between adiposity and lipid metabolism indicators and IVF/ICSI outcomes (i.e., hormone levels on the ovulatory triggering day, oocyte development outcomes, fertilization, early embryo development outcomes, and pregnancy outcomes) (all p < 0.05), as well as between adiposity and lipid metabolism indicators and WBC count (all p < 0.001). Increasing WBC count was associated with adverse oocyte and embryonic development outcomes (all p < 0.05). Mediation analyses suggested that increasing serum TG and LDL-C levels and decreasing serum HDL-C level were significantly associated with reduced high-quality Day 3 embryo count in PCOS women, with 21.51%, 9.75%, and 14.10% mediated by WBC count, respectively (all p < 0.05). We observed significant associations between lipid metabolism indicators and high-quality Day 3 embryo count in PCOS women, partially mediated by inflammation-related mechanisms, suggesting the potential intervention target for improving embryo quality in PCOS women.

Adiposity and lipid metabolism indicators mediate the adverse effect of glucose metabolism indicators on oogenesis and embryogenesis in PCOS women undergoing IVF/ICSI cycles

BackgroundPolycystic ovary syndrome (PCOS) women have high incidences of dyslipidemia, obesity, impaired glucose tolerance (IGT), diabetes, and insulin resistance (IR) and are fragile to female infertility. Obesity and dyslipidemia may be the intermediate biological mechanism for the associations between glucose metabolism dysfunction and abnormal oogenesis and embryogenesis.MethodsThis retrospective cohort study was performed at a university-affiliated reproductive center. A total of 917 PCOS women aged between 20 and 45 undergoing their first IVF/ICSI embryo transfer cycles from January 2018 to December 2020 were involved. Associations between glucose metabolism indicators, adiposity and lipid metabolism indicators, and IVF/ICSI outcomes were explored using multivariable generalized linear models. Mediation analyses were further performed to examine the potential mediation role of adiposity and lipid metabolism indicators.ResultsSignificant dose-dependent relationships were found between glucose metabolism indicators and IVF/ICSI early reproductive outcomes and between glucose metabolism indicators and adiposity and lipid metabolism indicators (all P < 0.05). Also, we found significant dose-dependent relationships between adiposity and lipid metabolism indicators and IVF/ICSI early reproductive outcomes (all P < 0.05). The mediation analysis indicated that elevated FPG, 2hPG, FPI, 2hPI, HbA1c, and HOMA2-IR were significantly associated with decreased retrieved oocyte count, MII oocyte count, normally fertilized zygote count, normally cleaved embryo count, high-quality embryo count, or blastocyst formation count after controlling for adiposity and lipid metabolism indicators. Serum TG mediated 6.0–31.0% of the associations; serum TC mediated 6.1–10.8% of the associations; serum HDL-C mediated 9.4–43.6% of the associations; serum LDL-C mediated 4.2–18.2% of the associations; and BMI mediated 26.7–97.7% of the associations.ConclusionsAdiposity and lipid metabolism indicators (i.e., serum TG, serum TC, serum HDL-C, serum LDL-C, and BMI) are significant mediators of the effect of glucose metabolism indicators on IVF/ICSI early reproductive outcomes in PCOS women, indicating the importance of preconception glucose and lipid management and the dynamic equilibrium of glucose and lipid metabolism in PCOS women.

The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1α/PPARα pathway

Prediabetes is a transitional state between normal blood glucose levels and diabetes, but it is also a reversible process. At the same time, as one of the most important tissues in the human body, the metabolic disorder of skeletal muscle is closely related to prediabetes. Huidouba (HDB) is a clinically proven traditional Chinese medicine with significant effects in regulating disorders of glucose and lipid metabolism. Our study aimed to investigate the efficacy and mechanism of HDB in prediabetic model mice from the perspective of skeletal muscle. C57BL/6J mice (6 weeks old) were fed a high-fat diet (HFD) for 12 weeks to replicate the prediabetic model. Three concentrations of HDB were treated with metformin as a positive control. After administration, fasting blood glucose was measured as an indicator of glucose metabolism, as well as lipid metabolism indicators such as total triglyceride (TG), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), free fatty acid (FFA), and lactate dehydrogenase (LDH). Muscle fat accumulation and glycogen accumulation were observed. The protein expression levels of p-AMPK, AMPK, PGC-1α, PPAR-α, and GLUT-4 were detected. After HDB treatment, fasting blood glucose was significantly improved, and TG, LDL-C, FFA, and LDH in serum and lipid accumulation in muscle tissue were significantly reduced. In addition, HDB significantly upregulated the expression levels of p-AMPK/AMPK, PGC-1α, PPAR-α, and GLUT-4 in muscle tissue. In conclusion, HDB can alleviate the symptoms of prediabetic model mice by promoting the AMPK/PGC-1α/PPARα pathway and upregulating the expression of GLUT-4 protein.

The Role of Asprosin in the Regulation and Mechanisms of Oxygen Transport in the Blood and the Gas Transmitter System in Men with Different Body Mass Index

The purpose of this study the role of asprosin in the regulation and mechanisms of oxygen transport in the blood and the gas transmitter system in men with different body mass index. The indicators of lipid and carbohydrate metabolism, as well as the oxygen transport function of the blood and the concentration of gas-transmitters nitrogen monoxide and hydrogen sulfide in it, were determined. A higher concentration of asprosin was found in individuals with an increased body mass index and grade I obesity. With an increased content of asprosin, there is a decrease in the main indicators of blood oxygenation and an increase in the affinity of hemoglobin for oxygen. An increase in the concentration of nitrogen monoxide and a decrease in hydrogen sulfide were revealed at a high content of asprosin, which may be important for the formation of the mechanisms of oxygen transport in the blood.